APA

Krauss G. L., Perucca E., Kwan P., Ben-Menachem E., Wang X., Shih J. J., Patten A., Yang H., Williams B. & Laurenza A. (20181211). Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307. : Epilepsia.

Chicago

Krauss Gregory L, Perucca Emilio, Kwan Patrick, Ben-Menachem Elinor, Wang Xue-Feng, Shih Jerry J, Patten Anna, Yang Haichen, Williams Betsy and Laurenza Antonio. 20181211. Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307. : Epilepsia.

Harvard

Krauss G. L., Perucca E., Kwan P., Ben-Menachem E., Wang X., Shih J. J., Patten A., Yang H., Williams B. and Laurenza A. (20181211). Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307. : Epilepsia.

MLA

Krauss Gregory L, Perucca Emilio, Kwan Patrick, Ben-Menachem Elinor, Wang Xue-Feng, Shih Jerry J, Patten Anna, Yang Haichen, Williams Betsy and Laurenza Antonio. Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307. : Epilepsia. 20181211.